Answers are grounded in this paper and cite their sources.
Background: Ventilator-associated pneumonia (VAP) is one of the most severe complications in traumatic brain injury (TBI) patients and is considered a risk factor for poor prognosis. The Aim of the work: The primary goal of this study was to assess the role of CD64 in the diagnosis of VAP in TBI in the intensive care unit (ICU) and monitoring antimicrobial treatment, the secondary goal was to detect the prevalence of commonly causing organisms of VAP. Methods: This study was conducted on 40 isolated traumatic brain injury patients with the Glasgow Coma Scale (GCS ≤ 8) admitted to ICU. Each patient was subjected to three times sets of samples; at the time of admission, after 3 days of admission, and after 7 days of admission. Routine investigations such as CBC, CRP, urine analysis, and routine blood culture plus standard bacterial culture for endotracheal aspirate (ETA). nCD64 % was evaluated by flowcytometry. Results: nCD64 % was significantly higher at the second time sample set when compared with the first and third sample time sets. ETA culture gave positive results in all patients at the first time sample set while, 90% and 85.8% in the second and third time sets respectively. Conclusion: nCD64 alone is not a dependable tool for diagnosis and monitoring of antibiotic response in mechanically ventilated patients. Clinical and radiological data collectively with ETA culture results are still the best for diagnosis of VAP in hospitalized patients
No takes yet. Share an insight, caveat, or question.
Mohamed et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: